BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20203086)

  • 1. SUMO modification regulates the transcriptional activity of MAML1.
    Lindberg MJ; Popko-Scibor AE; Hansson ML; Wallberg AE
    FASEB J; 2010 Jul; 24(7):2396-404. PubMed ID: 20203086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
    Grégoire S; Yang XJ
    Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification.
    Shan SF; Wang LF; Zhai JW; Qin Y; Ouyang HF; Kong YY; Liu J; Wang Y; Xie YH
    FEBS Lett; 2008 Nov; 582(27):3723-8. PubMed ID: 18948102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
    Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
    Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transcription factor activity by SUMO modification.
    Ouyang J; Valin A; Gill G
    Methods Mol Biol; 2009; 497():141-52. PubMed ID: 19107415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Something about SUMO inhibits transcription.
    Gill G
    Curr Opin Genet Dev; 2005 Oct; 15(5):536-41. PubMed ID: 16095902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylated SnoN represses transcription in a promoter-specific manner.
    Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
    J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo.
    Oyama T; Harigaya K; Sasaki N; Okamura Y; Kokubo H; Saga Y; Hozumi K; Suganami A; Tamura Y; Nagase T; Koga H; Nishimura M; Sakamoto R; Sato M; Yoshida N; Kitagawa M
    Development; 2011 Dec; 138(23):5235-46. PubMed ID: 22069191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation increases HIF-1alpha stability and its transcriptional activity.
    Bae SH; Jeong JW; Park JA; Kim SH; Bae MK; Choi SJ; Kim KW
    Biochem Biophys Res Commun; 2004 Nov; 324(1):394-400. PubMed ID: 15465032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis.
    Dequiedt F; Van Lint J; Lecomte E; Van Duppen V; Seufferlein T; Vandenheede JR; Wattiez R; Kettmann R
    J Exp Med; 2005 Mar; 201(5):793-804. PubMed ID: 15738054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IRF2 transcriptional activity by its sumoylation.
    Han KJ; Jiang L; Shu HB
    Biochem Biophys Res Commun; 2008 Aug; 372(4):772-8. PubMed ID: 18514056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional mechanisms by the coregulator MAML1.
    Saint Just Ribeiro M; Wallberg AE
    Curr Protein Pept Sci; 2009 Dec; 10(6):570-6. PubMed ID: 19751190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polycomb repressive complex 2 is a potential target of SUMO modifications.
    Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
    PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.